Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
331
331 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HS-10542Phase 22 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease
- HSK39297 300mgQDPhase 22 trials
Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)
- ICG318Phase 22 trials
iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- IsuzinaxibAPX-115Phase 22 trials
Aptabio Therapeutics, Inc. · Diabetic Kidney Disease (DKD), Contrast Induced Acute Kidney Injury
- JMT108Phase 22 trials
Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors
- KN060Phase 22 trials
Suzhou Alphamab Co., Ltd. · End-Stage Renal Disease Requiring Haemodialysis, Knee Arthroplasty, Total
- MRT-2359Phase 22 trials
Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC
- NKX019Phase 22 trials
Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis
- QLH12016Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Prostatic Neoplasms, Advanced Prostate Cancer
- R2R01Phase 22 trials
River 2 Renal Corp. · Acute Kidney Injury, Hepatorenal Syndrome
- R3R01Phase 22 trials
River 3 Renal Corp. · Diabetic Kidney Disease, Alport Syndrome, Focal Segmental Glomerulosclerosis
- REGN4336Phase 22 trials
Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)
- REGN5459Vonsetamig, BCMAxCD3Phase 22 trials
Regeneron · Chronic Kidney Disease (CKD), Relapsed Multiple Myeloma, Refractory Multiple Myeloma
- SGB-9768Phase 22 trials
Suzhou Sanegene Bio Inc. · PNH - Paroxysmal Nocturnal Hemoglobinuria, IgA Nephropathy (IgAN), C3 Glomerulopathy
- SLN12140Phase 22 trials
Linno Pharmaceuticals, Inc. · IgA Nephropathy (IgAN), Paroxysmal Nocturnal Hemoglobinuria (PNH)
- SSS17Phase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee
- STL303Phase 22 trials
Sitala Bio LTD · IgAN, Geographic Atrophy
- TTI-0102cysteamine-pantetheine disulfidePhase 22 trials
Thiogenesis Therapeutics, Inc. · Nephropathic Cystinosis, Cystinosis, MELAS Syndrome
- VNX001Phase 22 trials
Vaneltix Pharma, Inc. · Interstitial Cystitis, Bladder Pain Syndrome
- vudalimabPhase 22 trials
Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer
- WGI-0301Phase 22 trials
Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer
- XH-S003Phase 22 trials
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · PNH - Paroxysmal Nocturnal Hemoglobinuria, IgA Nephropathy
- ZalifrelimabPhase 22 trials
ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
- ZEN003694ZEN-3694Phase 22 trials
Zenith Epigenetics · mCRPC, Metastatic Castration-Resistant Prostate Cancer
- AB-2100Integrated Circuit T cellsPhase 21 trial
Arsenal Biosciences, Inc. · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence
- ACE-86225106Phase 21 trial
Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation
- ADI-212Phase 21 trial
Adicet Therapeutics · Prostate Cancer Metastatic
- ADX-097Phase 21 trial
Akebia Therapeutics · IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy
- AGS 22M6EAGS-22CEPhase 21 trial
Merck & Co. · Bladder Cancer
- AIC263029Phase 21 trial
AiCuris Anti-infective Cures AG · BK Virus Infection, BKV Infection, Kidney Transplant
- AION-301Phase 21 trial
AION Healthspan, Inc. · Chronic Kidney Disease Stage 3
- ALXN1920Phase 21 trial
AstraZeneca · Primary Membranous Nephropathy
- ALXN2030Phase 21 trial
AstraZeneca · Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores
- AMO959BY1298, BY101298Phase 21 trial
Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
- AMXI-5001Phase 21 trial
AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer
- AP306Phase 21 trial
R1 Therapeutics · Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, End Stage Renal Disease on Dialysis
- APL-101Phase 21 trial
Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer
- ARGX-121Phase 21 trial
argenx · Immunoglobulin A Nephropathy (IgAN)
- AS1986NSPhase 21 trial
Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging
- ASP5541PRL-02Phase 21 trial
Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
- AZD0516Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD0754Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD4144Phase 21 trial
AstraZeneca · Sepsis, Acute Kidney Injury
- AZD6621Phase 21 trial
AstraZeneca · Prostate Cancer
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD8359Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD9750Phase 21 trial
AstraZeneca · Prostate Cancer
- BAY3283142Phase 21 trial
Bayer · Chronic Kidney Disease
- CC-38Phase 21 trial
CuraCell TX AB · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.